Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
47
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Salvage radiotherapy improves survival in patients with locoregionally relapsed stage IE–IIE extranodal natural killer/T-cell lymphoma, nasal type

Qin Tong1 Department of Radiation Oncology, The First Affiliated Hospital of University of South China, Hengyang 421001, People’s Republic of China
,
Shuming Ouyang2 Department of Obstetrics and Gynecology, The First Affiliated Hospital of University of South China, Hengyang 421001, People’s Republic of China
,
Lingling Feng3 Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou 510060, People’s Republic of China
,
Hanyu Wang3 Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou 510060, People’s Republic of China
,
Yunfei Xia3 Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou 510060, People’s Republic of China
&
Yujing Zhang3 Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou 510060, People’s Republic of ChinaCorrespondence[email protected]
Pages 1083-1090 | Published online: 06 Jun 2018

References

  • FangHJinJWangWHWangSLZhouLQLiYXPrognostic factors and treatment outcomes for patients with stage II extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tractLeuk Lymphoma20145581832183724144309
  • ZhangJZhuMYWangL“Sandwich” Chemotherapy (CT) with Radiotherapy (RT) improves outcomes in patients with stage IE/IIE extranodal natural killer (NK)/T-cell LymphomasAsian Pac J Cancer Prev20131474061406623991953
  • AvilésANeriNFernándezRHuerta-GuzmánJNamboMJCombined therapy in untreated patients improves outcome in nasal NK/T lymphoma: results of a clinical trialMed Oncol201330363723797771
  • LiYXLiuQFWangWHFailure patterns and clinical implications in early stage nasal natural killer/T-cell lymphoma treated with primary radiotherapyCancer2011117225203521121523771
  • KimKChieEKKimCWKimIHParkCITreatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapyJpn J Clin Oncol20053511515681596
  • YangYZhangYLinXRole of radiotherapy in the combined treatment of patients with early stage extranodal nasal type NK/T-cell lymphoma and analysis of prognostic factorsChin J Radiat Oncol2009184285289
  • NiuSZhangYWenGPreliminary results of a phase II prospective clinical study of early-stage nasal NK/T-cell lymphoma with extended involved-field intensity-modulated radiotherapyChin J Radiat Oncol20154377381
  • ChesonBDHorningSJCoiffierBReport of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. NCI Sponsored International Working GroupJ Clin Oncol1999171244125310561185
  • ZhaoTLiYXWangSLSurvival benefit with salvage radiotherapy for patients with locoregionally recurrent extranodal NK/T cell lymphoma, nasal typeAnn Hematol201392332533223100164
  • LiCCTienHFTangJLTreatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphomaCancer2004100236637514716773
  • KoomWSChungEJYangWIAngiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpointsInt J Radiat Oncol Biol Phys20045941127113715234048
  • ZhangXXXieCHXuYSalvage treatment improved survival of patients with relapsed extranodal natural killer/t-cell lymphoma, nasal typeInt J Radiat Oncol Biol Phys200974374775219304409
  • ChenBLiYLiuQAnalysis of risk factors for late relapse in early-stage extranodal nasal-type NK/T-cell lymphoma after treatmentChin J Radiat Oncol201322175179 Available from: http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfszl201303001Accessed February 03, 2018
  • MaHHQianLTPanHFTreatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphomaMed Oncol201027379880619685292
  • LeeJChoSGChungSMRetrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL)Ann Hematol201392333334323180438
  • YamaguchiMTobinaiKOguchiMPhase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211J Clin Oncol200927335594560019805668
  • WangHLiYXWangWHMild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK/T-cell lymphomaInt J Radiat Oncol Biol Phys20128231115112121514070
  • KimSJParkYKimBSKimIKoYHKimWSExtranodal natural killer/T-cell lymphoma with long-tem survival and repeated relapses: does it indicate the presence of indolent subtype?Korean J Hematol201247320220623071475
  • JaccardAGachardNMarinBGELA and GOELAMS Inter-groupEfficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 studyBlood201111761834183921123825
  • YamaguchiMKwongYLKimWSPhase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group studyJ Clin Oncol201129334410441621990393

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.